LMNX News and Press, Luminex Corporation From 08/04/20

Luminex Corporation (LMNX) Q2 2020 Earnings Conference Call August 4, 2020 05:00 PM ET Company Participants Harriss Currie - Senior Vice President and Chief Financial Officer Nachum Shamir - President and Chief Executive Officer Conference Call Participants Andrew Brackmann -...

AUSTIN, Texas , Aug. 4, 2020 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced the retirement of its Chairman, G. Walter Loewenbaum , from its Board of Directors ("Board") effective August 3 , 2020.  "On behalf of Luminex's shareholders and Board, I would like t...

Luminex (NASDAQ: LMNX ) Q2 results : More news on: Luminex Corporation, Healthcare stocks news, Earnings news and commentary, , Stocks on the move, Read more ...

Luminex (NASDAQ: LMNX ) : Q2 GAAP EPS of $0.27 beats by $0.17 . More news on: Luminex Corporation, Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...

AUSTIN, Texas , Aug. 4, 2020 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced results for its second quarter ended June 30, 2020 . All amounts in this release are in conformity with U.S. generally accepted accounting principles ("GAAP"). CURRENT FINANCIAL H...

Biotech Pulse Biotechs continue to be one of the leading healthcare groups and along with diagnostics represent two of the best segments of healthcare. The first half saw biotechs recover quicker from the March selloff than most of the market, and reach a milestone that took 5 years to achie...

Luminex (NASDAQ: LMNX ) has submitted an emergency use authorization (EUA) request to the FDA for a new expanded version of its NxTAG Respiratory Pathogen Panel (RPP) to include the SARS-CoV-2 virus for high-throughput COVID-19 testing. More news on: Luminex Corporation, Heal...

AUSTIN, Texas , July 22, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an EUA request to the FDA for a new expanded version of its NxTAG ® Respiratory Pathogen Panel (RPP) to include the SARS-CoV-2 virus for high-throughput COVID-19 te...

AUSTIN, Texas , July 20, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2020 on Tuesday, August 4, 2020 . A press release announcing the results is scheduled for release after the close of tr...

THE FDA has issued Emergency Use Authorization (EUA) for Luminex's (NASDAQ: LMNX ) xMAP SARS-CoV-2 Multi-Antigen IgG Assay to identify the presence of antibodies in COVID-19 infected people. More news on: Luminex Corporation, Healthcare stocks news, Stocks on the move, Read mo...